AstraZeneca Says 'No Thanks' to Pfizer

WSJ Live
5.4K
23 views
  • About
  • Export
  • Add to
AstraZeneca rejects an improved takeover offer from Pfizer worth more than $106 billion, saying the proposal substantially undervalues the company. WSJ's Dana Cimilluca joins MoneyBeat with the details. Photo: Getty


Copyright 2014, Dow Jones & Company, Inc.

0 comments